Aripiprazole Orally Disintegrating Tablets 5mg (Suoqingning)

DescriptionAripiprazole is a dopamine D2 receptor partial agonist and serotonin 5-HT1A agonist, widely studied for its role in treating schizophrenia, bipolar disorder, and major depressive disorder. The orally disintegrating tablet (ODT) formulation allows for rapid systemic absorption, making it ideal for experimental designs that explore fast-onset antipsychotic activity. Contents hide 1 Aripiprazole Orally Disintegrating Tablets Product Specifications 2 Aripiprazole Orally Disintegrating Tablets Mechanism of Action 3 Research Applications 4 Handling & Storage 5 Research-Use Disclaimer Aripiprazole Orally Disintegrating Tablets Product SpecificationsParameterDetailsProduct NameAripiprazole Orally Disintegrating TabletsBrand NameSuoqingning (???)Active IngredientAripiprazoleCAS Number129722-12-9Molecular FormulaC23H27Cl2N3O2Molecular Weight448.39 g/molFormulationOrally Disintegrating Tablet (ODT)Strength5?mg per tabletPack Size60 tablets per boxApproval NumberH20213878 (NMPA, China)Drug Code86904647001065ManufacturerZhejiang Huahai Pharmaceutical Co., Ltd.Product Barcode6958439002925Storage ConditionsStore in a cool, dry place; avoid direct sunlight and moistureIntended UseFor laboratory research purposes onlyAripiprazole Orally Disintegrating Tablets Mechanism of ActionAripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at 5-HT2A receptors. Its unique pharmacodynamic profile makes it suitable for research in dopaminergic regulation, mood stabilization, and schizophrenia-related behaviors in animal and cellular models.Research ApplicationsPsychiatric Disease ModelsIdeal for studying schizophrenia, bipolar disorder, and treatment-resistant depression.Dopamine and Serotonin Pathway AnalysisUsed in receptor binding assays and signaling pathway exploration.Oral Drug Delivery StudiesFast-dissolving formulation aids in pharmacokinetic modeling and bioavailability assessments.Neurotransmitter Modulation ResearchEvaluates regulation of dopamine and serotonin in CNS experiments.Handling & StorageHandling: Use proper protective gear (gloves, lab coat) when handling tablets.Storage: Store below 25?°C. Keep dry and protect from light.Stability: Typically stable for 24–36 months in sealed original packaging.Research-Use DisclaimerThis product is intended exclusively for laboratory research use. It is not approved for human consumption, clinical diagnosis, or therapeutic use. Improper use may pose health risks. Handle in compliance with your institution’s biosafety standards.